Publications by authors named "Frederic Colland"

Claim this Profile
T
The Effect of Core Replacement on S64315, a Selective MCL-1 Inhibitor, and Its Analogues.
Szabolcs Sipos, Balázs Bálint, Zoltán B Szabó, Levente Ondi, Márton Csékei, Frederic Colland

ACS Omega· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of S64315, a Potent and Selective Mcl-1 Inhibitor.
Zoltan Szlavik, Marton Csekei, Attila Paczal, Zoltan B Szabo, Szabolcs Sipos, Frédéric Colland

J Med Chem· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular Activity.
Zoltan Szlávik, Levente Ondi, Márton Csékei, Attila Paczal, Zoltán B Szabó, Frederic Colland

J Med Chem· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia.
Donia M Moujalled, Giovanna Pomilio, Corina Ghiurau, Adam Ivey, Jessica Salmon, Frédéric Colland

Leukemia· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth.
Patrick Casara, James Davidson, Audrey Claperon, Gaëtane Le Toumelin-Braizat, Meike Vogler, Frédéric Colland

Oncotarget· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling.
Kei-Ichiro Arimoto, Sara Löchte, Samuel A Stoner, Christoph Burkart, Yue Zhang, Frédéric Colland

Nat Struct Mol Biol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models.
András Kotschy, Zoltán Szlavik, James Murray, James Davidson, Ana Leticia Maragno, Frédéric Colland

Nature· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TGIF governs a feed-forward network that empowers Wnt signaling to drive mammary tumorigenesis.
Ming-Zhu Zhang, Olivier Ferrigno, Zhe Wang, Mutsuko Ohnishi, Céline Prunier, Frédéric Colland

Cancer Cell· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of PHRF1 as a tumor suppressor that promotes the TGF-β cytostatic program through selective release of TGIF-driven PML inactivation.
Asma Ettahar, Olivier Ferrigno, Ming-Zhu Zhang, Mutsuko Ohnishi, Nathalie Ferrand, Frédéric Colland

Cell Rep· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme.
Céline Reverdy, Susan Conrath, Roman Lopez, Cécile Planquette, Cédric Atmanene, Frédéric Colland

Chem Biol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the elongasome core PBP2 : MreC complex of Helicobacter pylori.
Meriem El Ghachi, Pierre-Jean Matteï, Chantal Ecobichon, Alexandre Martins, Sylviane Hoos, Frédéric Colland

Mol Microbiol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ubiquitin-specific proteases as cancer drug targets.
Wolfgang Sippl, Vincent Collura, Frédéric Colland

Future Oncol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Listeria monocytogenes InlC protein interferes with innate immune responses by targeting the I{kappa}B kinase subunit IKK{alpha}.
Edith Gouin, Minou Adib-Conquy, Damien Balestrino, Marie-Anne Nahori, Véronique Villiers, Frédéric Colland

Proc Natl Acad Sci U S A· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological evaluation of 9-oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile analogues as potential inhibitors of deubiquitinating enzymes.
Matteo Colombo, Stefania Vallese, Ilaria Peretto, Xavier Jacq, Jean-Christophe Rain, Frédéric Colland

ChemMedChem· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional interaction between the ubiquitin-specific protease 25 and the SYK tyrosine kinase.
Michael Cholay, Céline Reverdy, Richard Benarous, Frédéric Colland, Laurent Daviet

Exp Cell Res· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The therapeutic potential of deubiquitinating enzyme inhibitors.
Frédéric Colland

Biochem Soc Trans· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells.
Frédéric Colland, Etienne Formstecher, Xavier Jacq, Céline Reverdy, Cécile Planquette

Mol Cancer Ther· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mst4 and Ezrin induce brush borders downstream of the Lkb1/Strad/Mo25 polarization complex.
Jean Paul ten Klooster, Marnix Jansen, Jin Yuan, Viola Oorschot, Harry Begthel, Frédéric Colland

Dev Cell· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of PCTA, a TGIF antagonist that promotes PML function in TGF-beta signalling.
Nourdine Faresse, Frédéric Colland, Nathalie Ferrand, Céline Prunier, Marie-Francoise Bourgeade

EMBO J· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of inducible systems to engineer conditional mutants of essential genes of Helicobacter pylori.
Ivo G Boneca, Chantal Ecobichon, Catherine Chaput, Aurélie Mathieu, Stéphanie Guadagnini, Frédéric Colland

Appl Environ Microbiol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting ubiquitin specific proteases for drug discovery.
Laurent Daviet, Frédéric Colland

Biochimie· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patented small molecule inhibitors in the ubiquitin proteasome system.
Philippe Guédat, Frédéric Colland

BMC Biochem· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The disintegrin and metalloproteinase ADAM12 contributes to TGF-beta signaling through interaction with the type II receptor.
Azeddine Atfi, Emmanuelle Dumont, Frédéric Colland, Dominique Bonnier, Annie L'helgoualc'h

J Cell Biol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of active and inactive siRNA targeting the mitotic kinesin Eg5 impairs silencing efficiency in several cancer cell lines.
Etienne Formstecher, Celine Reverdy, Mickael Cholay, Cecile Planquette, Virginie Trouplin, Frederic Colland

Oligonucleotides· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP.
Armando van der Horst, Alida M M de Vries-Smits, Arjan B Brenkman, Miranda H van Triest, Niels van den Broek, Frédéric Colland

Nat Cell Biol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis